Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Plunges 7%; BSE HEALTHCARE Index Down 1.0%
Mon, 7 Oct 13:6

NEULAND LABS Plunges 7%; BSE HEALTHCARE Index Down 1.0%Image source: KanawatTH/www.istockphoto.com

NEULAND LABS share price has plunged 7% and is presently trading at Rs 11,211.2.

Meanwhile, the BSE HEALTHCARE index is at 43,134.9 (down 1.0%).

Among the top losers in the BSE HEALTHCARE index today are GSK Pharma (down 4.2%) and SUVEN PHARMACEUTICALS (down 4.1%).

ASTRAZENECA PHARMA (up 3.7%) and Natco Pharma (up 2.2%) are among the top gainers today.

Over the last one year, NEULAND LABS has moved up from Rs 3,741.2 to Rs 11,211.2, registering a gain of Rs 7,470.0 (up 199.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,428.9 to 43,134.9, registering a gain of 51.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 149.8%), SUVEN PHARMACEUTICALS (up 100.4%) and Glenmark Pharma (up 97.4%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,178.8 (down 0.6%).

The top losers among the BSE Sensex today are NTPC (down 4.1%) and MUNDRA PORT & SEZ (down 3.8%). The most traded stocks in the BSE Sensex are Tata Steel and Axis Bank.

In the meantime, NSE Nifty is at 24,793.9 (down 0.9%). NTPC and MUNDRA PORT & SEZ are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,512.1 to 81,178.8, registering a gain of 15,666.7 points (up 23.9%).

NEULAND LABS Financial Update...

NEULAND LABS net profit grew 58.2% YoY to Rs 979 million for the quarter ended June 2024, compared to a profit of Rs 619 million a year ago. Net sales rose 21.1% to Rs 4,396 million during the period as against Rs 3,630 million in April-June 2023.

For the year ended March 2024, NEULAND LABS reported 83.5% increase in net profit to Rs 3,001 million compared to net profit of Rs 1,635 million during FY23. Revenue of the company grew 30.8% to Rs 15,586 million during FY24.

The current Price to earnings ratio of NEULAND LABS, based on rolling 12 month earnings, stands at 42.8.


Equitymaster requests your view! Post a comment on "NEULAND LABS Plunges 7%; BSE HEALTHCARE Index Down 1.0%". Click here!